Clinical Trials Sponsored by Nordic Nanovector

Total 2609 results

Cordis Corporation

Completed

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease (ACHILLES)

Peripheral Arterial Diseases

Germany
Cordis Corporation

Completed

A Study of the SMART Stent in the Treatment SFA Disease. (SIROCCO)

Peripheral Artery Disease

Germany
Cordis Corporation

Completed

A Multi-center Post-Market Surveillance Registry (E-SELECT)

Coronary Artery Disease

Switzerland
Cordis Corporation

Completed

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

In-Stent Restenosis

United States
Cordis Corporation

Completed

The Study to Compare SMART Nitinol Stent and Balloon Angioplasty (SIT-UP)

Superficial Femoral Artery Occlusions

Switzerland
Cordis Corporation

Completed

The Study to Treat Superficial Femoral Artery Occlusions. (SUPER UK)

Arterial Occlusive Diseases

United Kingdom
Cordis Corporation

Completed

The Arterial Revascularization Therapies Study Part II. (ARTS II)

Coronary Artery Disease

Netherlands
Cordis Corporation

Completed

Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)

Abdominal Aortic Aneurysm

United States
Cordis Corporation

Terminated

The Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions. (DURAVEST)

Arterial Occlusive Diseases

Netherlands
Cordis Corporation

Completed

The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity. (DISCOVER)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions. (DOMINO)

Coronary Artery Disease

United Kingdom
Cordis Corporation

Completed

A Comparison of Coated and Uncoated Stents in Renal Artery Treatment. (GREAT)

Renal Artery Stenosis

France, Germany, Netherlands
Cordis Corporation

Completed

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions. (TROPICAL)

Coronary Artery Disease

Belgium, Germany
Cordis Corporation

Completed

A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. (BIFURCATION)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)

Coronary Artery Disease
Cordis Corporation

Completed

FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent

Coronary Artery Disease

France
Cordis Corporation

Completed

Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus

Coronary Artery Disease

France
Rigshospitalet, Denmark
The Novo Nordic Foundation; Laegeforeningens Forskningsfond

Recruiting

Hypoxemia in the First 24 Hours After Trauma - an Observational Study (HYPOX24)

Hypoxia | Trauma | Trauma Injury | Oxygen Deficiency | Hypoxemia

Denmark
Bavarian Nordic
Biomedical Advanced Research and Development Authority

Completed

Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial

Smallpox

United States
Copenhagen University Hospital at Herlev
Nordic Lymphoma Group

Completed

Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV

Diffuse Large-Cell Lymphoma

Denmark
Danish Pain Research Center
UCB Nordic A/S

Completed

Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury

Pain | Injuries, Spinal Cord

Denmark
Enlivex Therapeutics Ltd.
Nordic Bioscience Clinical Development (NBCD)

Recruiting

Study of Intra-articular Allocetra in Knee Osteoarthritis

Osteoarthritis, Knee

Israel, Denmark
Nordic Society of Gynaecological Oncology - Clinical...

Recruiting

Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype (HERO)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

Denmark
The Royal Orthopaedic Hospital NHS Trust
Stryker Nordic

Recruiting

A Comparison of Impingement Free Range of Motion With CT Scan After Manual and Robotic Total Hip Replacement

Post-traumatic Osteoarthritis | Inflammatory Arthritis | Hip Osteoarthritis | Avascular Necrosis of Hip | Congenital Hip Problems

United Kingdom
Bavarian Nordic
Emergent BioSolutions; Catalyst Clinical Research, LLC

Completed

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

Chikungunya Virus

United States
Hospital for Special Surgery, New York
Stryker Nordic

Active, not recruiting

Metal Ion Levels in Stryker Trident II Tritanium System With Modular Dual Mobility (MDM) Liner, Ceramic Head, and SecurFit Advanced Stems

Hip Pain

United States
Hospital for Special Surgery, New York
Stryker Nordic

Completed

Maveric Magnetic Resonance Imaging Used to Study Detailed Bone Apposition and Fixation of the Stryker Trident II Tritanium System

Chronic Hip Pain

United States
Nordic Society of Gynaecological Oncology - Clinical...

Withdrawn

Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer

Ovarian Cancer

Norway, Denmark, Finland
University of Oslo
Nordic Institute of Dental Materials

Unknown

Ceramic Tooth Restorations - a Comparison Study

Dental Restoration Failure of Marginal Integrity

Norway
Nordic Society of Gynaecological Oncology - Clinical...

Completed

Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane

Ovarian Cancer | Peritoneal Cancer | Cancer of the Fallopian Tube
Nordic Society of Gynaecological Oncology - Clinical...

Completed

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

Ovarian Epithelial Cancer Recurrent

Denmark, Finland, Norway
Nordic Society of Gynaecological Oncology - Clinical...

Completed

Exemestane in Advanced and Recurrent Endometrial Carcinoma

Endometrial Cancer

Norway
Dr. Kerstin de Wit
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Recruiting

Improving Emergency Department Testing for Deep Vein Thrombosis

Deep Vein Thrombosis (DVT)

Canada
Dr. Kerstin de Wit
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Completed

Adjust-Unlikely PE

Pulmonary Embolism (Diagnosis)

Canada
Jacob Pontoppidan Thyssen
The Novo Nordic Foundation

Recruiting

Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)

Chronic Hand Eczema

Denmark
Royal Devon and Exeter NHS Foundation Trust
Stryker Nordic

Recruiting

Traditional Versus Alternative Alignment in TKR

Osteo Arthritis Knee

United Kingdom
Swiss Group for Clinical Cancer Research
Nordic Lymphoma Group

Terminated

Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma

Follicular Lymphoma

Sweden, Finland, Denmark, Norway, Switzerland, Austria
Stichting Hemato-Oncologie voor Volwassenen Nederland
Nordic Lymphoma Group

Active, not recruiting

CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.

CLL

Netherlands, Denmark
Lund University Hospital
Celgene; Janssen, LP; Nordic Lymphoma Group

Completed

A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma (PHILEMON)

Relapsed/Refractory Mantle Cell Lymphoma

Finland, Denmark, Sweden, Norway
Rigshospitalet, Denmark
Nordic Society for Pediatric Hematology and Oncology

Completed

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy (ALL2008con)

Acute Lymphoblastic Leukemia

Finland, Denmark, Iceland, Norway, Sweden
Nordic Pharma, USA
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

A Comparator Trial on the Relative Efficacy of Two Triglyceride Forms of Fish Oil

Healthy Volunteers

Canada
Nordic Pharma, USA
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Withdrawn

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction (PrOteCT)

Mixed Hyperlipoproteinemia
ACO Hud Nordic AB
Smerud Medical Research International AS

Completed

A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema

Hand Eczema

Norway
Royal Devon and Exeter NHS Foundation Trust
Stryker Nordic

Active, not recruiting

Fixed Versus Adjustable Loop in ACL Reconstruction

Anterior Cruciate Ligament Reconstruction

United Kingdom
Lawrence Fong
Bavarian Nordic

Terminated

Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer

Prostatic Neoplasms

United States
Henrik Gregersen
Nordic Myeloma Study Group

Unknown

Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support (CARFI)

Multiple Myeloma

Finland, Denmark, Sweden, Norway, Lithuania
Turku University Hospital
Novartis; Academy of Finland; Stryker Nordic

Completed

Efficacy of Zoledronic Acid in Enhancement of Early Stability of Cementless Primary Hip Prosthesis

Hip Osteoarthritis

Finland
Nordic Pharma, USA
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

A Marketing-oriented Study to Evaluate the Comparative Bioavailability of Omega-3 Fatty Acids From Four Different Natural Health Products

Comparative Bioavailability

Canada

Clinical Trials Sponsored by Nordic Nanovector

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations